These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Silvilairat S; Cabalka AK; Cetta F; Grogan M; Hagler DJ; O'Leary PW Congenit Heart Dis; 2008; 3(4):262-8. PubMed ID: 18715460 [TBL] [Abstract][Full Text] [Related]
25. Fenestration of extracardiac fontan and reversal of protein-losing enteropathy: case report. Lemes V; Murphy AM; Osterman FA; Laschinger JC; Kan JS Pediatr Cardiol; 1998; 19(4):355-7. PubMed ID: 9636262 [TBL] [Abstract][Full Text] [Related]
26. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment. Meadows J; Jenkins K Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233 [TBL] [Abstract][Full Text] [Related]
27. Oral budesonide as a therapy for protein-losing enteropathy in children after the Fontan operation. Gursu HA; Erdogan I; Varan B; Oktay A; Ozcay F; Ozkan M; Aslamaci S J Card Surg; 2014 Sep; 29(5):712-6. PubMed ID: 24889258 [TBL] [Abstract][Full Text] [Related]
29. Recurrent protein-losing enteropathy and tricuspid valve insufficiency in a transplanted heart: a causal relationship? Aggarwal S; Delius RE; Walters HL; L'Ecuyer TJ Congenit Heart Dis; 2012; 7(3):E10-3. PubMed ID: 21801319 [TBL] [Abstract][Full Text] [Related]
30. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone. Grattan MJ; McCrindle BW Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490 [TBL] [Abstract][Full Text] [Related]
31. Reversal of protein-losing enteropathy in a child with Fontan circulation is correlated with central venous pressure after heart transplantation. Holmgren D; Berggren H; Wåhlander H; Hallberg M; Myrdal U Pediatr Transplant; 2001 Apr; 5(2):135-7. PubMed ID: 11328553 [TBL] [Abstract][Full Text] [Related]
35. Protein-Losing Enteropathy and Plastic Bronchitis After the Fontan Operation. Peyton C Crit Care Nurse; 2018 Dec; 38(6):e5-e12. PubMed ID: 30504504 [TBL] [Abstract][Full Text] [Related]
36. Serum cholesterol in idiopathic and lupus-related protein-losing enteropathy. Kim YG; Lee CK; Byeon JS; Myung SJ; Oh JS; Nah SS; Moon HB; Yoo B Lupus; 2008 Jun; 17(6):575-9. PubMed ID: 18539712 [TBL] [Abstract][Full Text] [Related]
38. Protein-losing enteropathy secondary to Fontan procedure resolved after cardiac transplantation. Sierra C; Calleja F; Picazo B; Martinez-Valverde A J Pediatr Gastroenterol Nutr; 1997 Feb; 24(2):229-30. PubMed ID: 9106114 [No Abstract] [Full Text] [Related]
39. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations. Fujii T; Shimizu T; Takahashi K; Kishiro M; Ohkubo M; Akimoto K; Yamashiro Y J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):577-80. PubMed ID: 14581800 [TBL] [Abstract][Full Text] [Related]
40. Stents in the successful management of protein-losing enteropathy after fontan. Shahda S; Zahra M; Fiore A; Jureidini S J Invasive Cardiol; 2007 Oct; 19(10):444-6. PubMed ID: 17906348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]